In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal Antibody - James G. Krueger; Brian S. Kim; Stephan Weidinger; Yoko Kataoka; John T. O'Malley; Karl Yen; Cassie Van Krinks; Jose Vela (Acta Dermato-Venereologica)